Skip to main content
Premium Trial:

Request an Annual Quote

Michael Barber, David Snyder, Arthur Stytkowski

GE appointed Michael Barber as chief technology officer of GE Healthcare and a vice president of technology, diagnostic imaging, the company said this week.
He has been the general manager of technology since May 2005 and has been with GE since 1981. He held other positions in GE Healthcare, including general manager for components engineering and general manager for global components operations.
Barber received his bachelors' degree in electrical engineering from the Milwaukee School of Engineering.

NimbleGen Systems named David Snyder as chief financial officer last week.
He has over 15 years experience as a chief financial officer for companies spanning several industries, including technology, real estate, and diversified manufacturing.
Snyder graduated from Harvard Business School with high honors and was designated a Baker Scholar. He received his BA from Ottawa University.

DNAPrint Genomics retained Arthur Stytkowski as a consultant on scientific, medical, regulatory, and patent issues, the company said last week.
Stytkowski is the director of the laboratory for cell and molecular biology at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School. He is an associate professor in the department of medicine at Harvard Medical School and a member of the division of hematology and oncology at BIDMC.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.